The American Academy of Pediatrics is splitting from the federal government in its recommendations on which children should ...

The health and human services secretary, Robert F. Kennedy Jr., is accusing the American Academy of Pediatrics of a ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read an analysis of MRNA stock now.

A new study shows that while RSV mostly affects younger kids, the often-overlooked human metapneumovirus also hospitalizes ...

Pfizer is a solid dividend stock. Its forward yield currently tops 7%, and the company has increased its payouts by 19.5% in ...

Moderna, Inc.'s Q2 2025 earnings highlight a steep revenue decline post-pandemic, with just $0.1bn in revenue and a $(0.8bn) net loss. Learn more on MRNA stock here.

Merck MRK stock has declined 4% since it announced second-quarter results on July 29 before market open. While the company’s ...

As biotech is making a push to protect cattle from the screwworm, delve into the broader field of livestock-specific biotech.

Scientists comment on Robert F. Kennedy Jr cancelling funding for mRNA vaccines. Prof Adam Finn, Professor of Paediatrics, University of Bristol, said: ...

Moderna's RSV vaccine for adults aged 60 years and older has been approved ... Moderna continues to make progress on advancing mRNA-4157 in the clinic. In collaboration with Merck, the Phase 3 ...